Hyku

Hyku

Edit info

  • Founded: 2021
  • Location: Lexington, MA
  • Employee range: 1-50
  • Clinical stage: RD
  • Therapy area: Undisclosed
  • Lead product: Undisclosed
  • Funding: 10 - 100M


www.hykubiosciences.com

linkedin.com

job board


About:

Hyku Biosciences is pioneering the development of precision covalent medicines. Their approach leverages a proprietary platform that combines chemoproteomics, computational biology, and custom machine learning algorithms. This allows Hyku to target previously undruggable proteins by focusing on non-cysteine amino acids in the proteome. By expanding beyond cysteine, Hyku unlocks a wider range of potential drug targets. Hyku is developing covalent inhibitors for various cancer targets, including KRAS and FGFR mutations often implicated in tumor growth.

Jobs:

Post a job


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com